BioPharma Credit plc
(the "Company")
TOTAL VOTING RIGHTS
In conformity with the Disclosure Guidance and Transparency Rules, the Company notifies the market that the issued share capital and voting rights of the Company, as at 30 April 2023, were as follows:
| Class of share | Total number of shares in circulation | Number of voting rights attached to each share | Total number of voting rights of shares in circulation | Number of shares held in treasury (carrying no voting rights attached until issued) | Total number of shares in issue |
| Ordinary $0.01 shares | 1,317,675,556 | 1 | 1,317,675,556 | 56,256,511 | 1,373,932,067 |
The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in BioPharma Credit PLC under the FCA's Disclosure Guidance and Transparency Rules.
2 May 2023
LEI: 213800AV55PYXAS7SY24
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
